Bill Sponsor
BILLSPONSOR
Bill Sponsor
Politicians
Bills
House Bill 6895
118th Congress(2023-2024)
Defense Production and Active Pharmaceutical Ingredients Act
Introduced
Introduced
Introduced in House on Dec 22, 2023
Overview
Text
Introduced in House 
Dec 22, 2023
About Linkage
Multiple bills can contain the same text. This could be an identical bill in the opposite chamber or a smaller bill with a section embedded in a larger bill.
Bill Sponsor regularly scans bill texts to find sections that are contained in other bill texts. When a matching section is found, the bills containing that section can be viewed by clicking "View Bills" within the bill text section.
Bill Sponsor is currently only finding exact word-for-word section matches. In a future release, partial matches will be included.
Introduced in House(Dec 22, 2023)
Dec 22, 2023
About Linkage
Multiple bills can contain the same text. This could be an identical bill in the opposite chamber or a smaller bill with a section embedded in a larger bill.
Bill Sponsor regularly scans bill texts to find sections that are contained in other bill texts. When a matching section is found, the bills containing that section can be viewed by clicking "View Bills" within the bill text section.
Bill Sponsor is currently only finding exact word-for-word section matches. In a future release, partial matches will be included.
Jump To
H. R. 6895 (Introduced-in-House)


118th CONGRESS
1st Session
H. R. 6895


To amend the National Defense Authorization Act for Fiscal Year 2023 to extend Federal support for bioindustrial manufacturing processes to include support for the manufacturing of certain pharmaceutical ingredients.

IN THE HOUSE OF REPRESENTATIVES

December 22, 2023

Ms. Slotkin introduced the following bill; which was referred to the Committee on Armed Services

A BILL

To amend the National Defense Authorization Act for Fiscal Year 2023 to extend Federal support for bioindustrial manufacturing processes to include support for the manufacturing of certain pharmaceutical ingredients.

Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,

SECTION 1. Short title.

This Act may be cited as the “Defense Production and Active Pharmaceutical Ingredients Act”.

SEC. 2. Modification of support for research and development of bioindustrial manufacturing processes.

Section 215(c)(1) of the James M. Inhofe National Defense Authorization Act for Fiscal Year 2023 (Public Law 117–263; 10 U.S.C. 4841 note) is amended by inserting “active pharmaceutical ingredients, key starting materials for such ingredients,” after “commodity chemicals,”.